18 Spam-Free Article(s) Found
Sort:
Relevance
Like
Date
Filter:
7d
All
DeepLinks
Article Searches
Why Eli Lilly Stock Beat the Market Today While ResMed and AdaptHealth Sank https://www.fool.com/investing/2024/04/17/why-eli-lilly-stock-beat-the-market-today-while-re/?source=iedfolrf0000001 Apr 17, 2024 - The company published some very good news from the lab, although it wasn't so encouraging for smaller rivals.
Needham sees BSX, CNMD, RMD beating Street, despite medtech slow down https://seekingalpha.com/news/4089446-needham-sees-bsx-cnmd-rmd-beating-street-despite-medtech-slow-down?source=feed_sector_healthcare Apr 14, 2024 - Needham estimates Q1 medtech sales grew less than expected, but that Boston Scientific, CONMED, ResMed and Surmodics should still be able to beat the Street. Read more here.
Turning 73 in 2024? It's Time to Get Ready for Your First RMD. https://www.fool.com/retirement/2024/04/14/turning-73-in-2024-its-time-to-get-ready-for-your/?source=iedfolrf0000001 Apr 14, 2024 - It's important to know the rules of RMDs so you can plan accordingly and avoid penalties.
Here's Why Investors Should Buy ResMed (RMD) Stock Now https://www.zacks.com/stock/news/2248659/here-s-why-investors-should-buy-resmed-rmd-stock-now?cid=CS-ZC-FT-analyst_blog|rank_focused-2248659 Apr 01, 2024 - Investors are optimistic about ResMed (RMD) led by the strong uptake of the myAir app with Air 11 systems.
Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick https://www.zacks.com/stock/news/2238061/are-you-a-momentum-investor-this-1-stock-could-be-the-perfect-pick?cid=CS-ZC-FT-tale_of_the_tape|zacks_education_momentum_score-2238061 Mar 08, 2024 - Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Here's Why Investors Should Retain ResMed (RMD) Stock for Now https://www.zacks.com/stock/news/2228766/here-s-why-investors-should-retain-resmed-rmd-stock-for-now?cid=CS-ZC-FT-analyst_blog|rank_focused-2228766 Feb 20, 2024 - Investors are optimistic about ResMed's (RMD) increased adoption of AirSense10 and AirSense11 devices.
ResMed (RMD) to Treat Sleep Apnea With New AirCurve 11 (Revised) https://www.zacks.com/stock/news/2227458/resmed-rmd-to-treat-sleep-apnea-with-new-aircurve-11-revised?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2227458 Feb 16, 2024 - ResMed's (RMD) new AirCurve11 series incorporates MyAir and AirView digital health apps to provide maximum comfort and support during therapy.
ResMed (RMD) to Treat Sleep Apnea With New AirCurve 11 Device https://www.zacks.com/stock/news/2225610/resmed-rmd-to-treat-sleep-apnea-with-new-aircurve-11-device?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2225610 Feb 13, 2024 - ResMed's (RMD) new AirCurve11 series incorporates myAir and AirView digital health apps to provide maximum comfort and support during therapy.
Why ResMed (RMD) is a Top Growth Stock for the Long-Term https://www.zacks.com/stock/news/2221023/why-resmed-rmd-is-a-top-growth-stock-for-the-long-term?cid=CS-ZC-FT-tale_of_the_tape|zacks_education_growth_score-2221023 Feb 05, 2024 - The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
ResMed (RMD) Q2 Earnings Beat Estimates, Margins Expand https://www.zacks.com/stock/news/2216027/resmed-rmd-q2-earnings-beat-estimates-margins-expand?cid=CS-ZC-FT-analyst_blog|earnings_article-2216027 Jan 25, 2024 - ResMed's (RMD) Q2 results reflect cost discipline to support an acceleration in profitability.

Pages: 12

Page 1